30 April 2020

Dr. Kongkrapan Intarajang, CEO of GC, together with the executive team, present CoviClear, or the silver nanoparticle disinfection unit, to help reduce the risk of contracting COVID-19, along with PPE, to Ramathibodi Hospital

GC Group, led by Dr. Kongkrapan Intarajang, Chief Executive Officer of GC, and his executive team presented the silver nanoparticle disinfection unit CoviClear, which is designed to lower the risk of contracting COVID-19 along with raw materials to produce two types of disinfectant liquid: triethanolamine (TEA), for which GC is the only manufacturer in Thailand, and pharmaceutical-grade glycerine for use in CoviClear, to Ramathibodi Hospital. The donation was received by Dr. Sukit Yamwong, Director of Somdech Phra Debaratana Medical Center (SDMC) and Acting Deputy Dean of the Mission Support Unit, and Professor Emeritus Dr. Aram Rojanasakul, Managing Director of RFS Company Limited.

In addition, GC presented 500 3D Printed Face Shields, 500 disposable gowns and eight partition units, both made from InnoPlus HDPE, to help reduce the risk of infections for medical professionals.

Back

News

Dr. Kongkrapan Intarajang, CEO of GC, together with the executive team, present CoviClear, or the silver nanoparticle disinfection unit, to help reduce the risk of contracting COVID-19, along with PPE, to Ramathibodi Hospital

GC Highlights on Implementing 3Rs and Circular Economy on Waste Management in Asia Pacific